Research Center for Vaccine Technology & Development, Institute of Tropical Disease (RCVTD-ITD) Airlangga University has succeeded in developing a COVID-19 vaccine in an inactive platform, where the seed vaccine (Seed Vaccine) is the result of isolates from Prof. Dr. Fedik Abdul Rantam., DVM . RCVTD-ITD Universitas Airlangga which is a collaboration between UNAIR & RSUD Dr. Soetomo and now it has been successfully applied to the community under the name INAVAC. After going through clinical trials that required thousands of subjects as volunteers starting from Phase I to Phase III involving hospitals as well as RSUD Dr. Soetomo/ Teaching Hostpital, RS UNAIR, RSSA Malang, RSUD Paru Jember, RSUD Soebandi Jember. This success is the realization of the Triple Helix concept between academia, government & industry, namely the Ministry of Health, BADAN POM-RI, PT. Biotis Pharmaceutical Indonesia. The award as a vaccine developer from the BADAN POM-RI was given to UNAIR Chancellor, head of COVID-19 vaccine developer, clinical trial coordinator, & clinical trial researcher on 15 February 2023 at Ciputra Artpreneur Theater Jakarta
Picture’s Source: antaranews.com
